Cite
MLA Citation
B Thier et al.. “L5 RIG-I activation enhances melanoma immunogenicity and improves anti-tumor T cell responses in combination with anti-PD-1 immune checkpoint blocking antibodies.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A3. http://access.bl.uk/ark:/81055/vdc_100177565747.0x000004